Associate Professor, Medicine, University of Alabama School of Medicine
Rheumatology
Dr. Jeffrey R. Curtis, MD
|
|
Give Review
Jeffrey R. Curtis practices Rheumatology. He attended University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine He received 2 awards: "Meaningful Use Stage 1 Certification" and "Fellow (FACR)". Jeffrey R. Curtis, MD is also published. He has 100 publications published. The lastest publication: "Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid arthritis.' He accepts all Medicare patients.
Publications
- Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
- Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid Arthritis.
- Methotrexate Adherence Questionnaire: a New Tool to Assess Adherence in Patients Treated with Methotrexate.
- Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
- Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin ...
- DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.
- The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid Arthritis patients previously treated with an anti-tumour necros...
- Risk of Hospitalized Infection among Biologic-Treated Rheumatoid Arthritis Patients Concurrently Treated with Denosumab.
- Comprehensive appraisal of MRI findings in sustained RA remission: Sub-study of the TEAR trial.
- Reply to Letter to the Editor: Differential risk of herpes zoster infection with biologic use in rheumatoid Arthritis.
- Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid Arthritis.
- Proceedings from the ACR Reproductive Health Summit: The management of fertility, pregnancy and lactation in women with autoimmune and systemic inflammatory Diseases.
- Impact of biologics with and without concomitant MTX and at reduced doses in older rheumatoid Arthritis patients.
- Recent trends in medication usage for the treatment of juvenile idiopathic Arthritis and the influence of tumor necrosis factor inhibitors.
- Persistence and Dose Escalation of Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis.
- Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the veterans health administration.
- Risks of Herpes Zoster in Patients with Rheumatoid Arthritis According to Biologic Disease Modifying Therapy.
- Effect of Self-referral on Bone Mineral Density Testing and Osteoporosis Treatment.
- Vaccinations for rheumatoid Arthritis.
- Estimating Effectiveness and Cost of Biologics for Rheumatoid Arthritis: Application of a Validated Algorithm to Commercial Insurance Claims.
- Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.
- Linkage of a de-identified United States rheumatoid Arthritis registry with administrative data to facilitate comparative effectiveness research.
- The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid Arthritis.
- Considerations in using registry and health plan data for studying pregnancy in rheumatic Diseases.
- Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid Arthritis.
- The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine.
- Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies.
- Trends in the utilization and outcomes of medicare patients hospitalized for hip fracture, 2000-2008.
- Risk of hospitalised infection in rheumatoid Arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.
- A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab.
- Continued Benefit of Tocilizumab Plus Disease-modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis and Inadequate Clinical Responses by Week 8 of...
- Risk of hospitalized bacterial infections associated with biologic treatment among U.S. Veterans with Rheumatoid Arthritis.
- Use of health plan combined with registry data to predict clinical trial recruitment.
- Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid Arthritis.
- Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis.
- High Plasma Levels of Vitamin C and E Are Associated with Incident Radiographic Knee OsteoArthritis.
- Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid Arthritis.
- Patient Perspectives on Achieving Treat-to-Target Goals: A Critical Examination of Patient-Reported Outcomes.
- Multimodal intervention to improve Osteoporosis care in home health settings: results from a cluster randomized trial.
- Identifying newly approved medications in Medicare claims data: a case study using tocilizumab.
- Use of pharmacologic agents for the primary prevention of Osteoporosis among older women with low bone mass.
- TNFs, TB, testing, and treatment: Teeing up the questions.
- Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study.
- Death, Debility, and Destitution Following Hip Fracture.
- Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune Diseases.
- Trends in the Use of Biologic Therapies among Rheumatoid Arthritis Patients Enrolled in the U.S. Medicare Program.
- Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease.
- Effectiveness and cost per responder with first-line biologics for rheumatoid Arthritis using a validated, claims-based algorithm in a large us commercial health plan.
- Effectiveness of second line biologic use in rheumatoid Arthritis after switching from first-line biologics.
- Using a validated algorithm to evaluate the effectiveness of biologics for rheumatoid Arthritis in a commercial claims database.
- New methods for determining comparative effectiveness in rheumatoid Arthritis.
- Validity of diagnostic codes and prevalence of psoriasis and psoriatic Arthritis in a managed care population, 1996-2009.
- Validation of methotrexate-first strategy in early poor prognosis rheumatoid Arthritis: Results from a randomized, double-blind, 2-year trial.
- Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid Arthritis.
- Nature and correlates of post-traumatic stress symptomatology in lung transplant recipients.
- Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
- Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009.
- Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial.
- Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid Arthritis: results from the treatment of early aggressive rheumatoid Arthritis ...
- Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
- Incidence of selected opportunistic infections among children with juvenile idiopathic Arthritis.
- Further evaluation of a claims-based algorithm to determine the effectiveness of biologics for rheumatoid Arthritis using commercial claims data.
- Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: the Study of Osteoporotic Fractures and Medicare claims data.
- Osteoporosis medication adherence: Physician perceptions vs. patients' utilization.
- Changes in lipoproteins associated with treatment with methotrexate or combination therapy in early rheumatoid Arthritis: Results from the TEAR trial.
- Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis.
- Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System.
- Tumor necrosis factor ? inhibitor therapy and cancer risk in chronic immune-mediated Diseases.
- Mycobacterial Diseases and antitumour necrosis factor therapy in USA.
- Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.
- Low Hemoglobin Levels and Recurrent Falls in U.S. Men and Women: Prospective Findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) Cohort.
- Association between anti-TNF-? therapy and interstitial lung Disease.
- Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid Arthritis: a 1-week sub-study of a randomised controlled trial (Rapid Onset and S...
- Generic alendronate use among medicare beneficiaries: are part d data complete?
- A close examination of health care expenditures related to fractures.
- Defining physiologically "normal" vitamin D in African Americans.
- Rates of hospitalized bacterial infection associated with juvenile idiopathic Arthritis and its treatment.
- A randomized trial of a mailed intervention and self-scheduling to improve Osteoporosis screening in postmenopausal women.
- Physician explanation forapparent gaps in the quality of rheumatology care: Results from the U.S. medicare physician quality reporting system.
- Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.
- Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated Diseases.
- Management of Osteoporosis among the Elderly with Other Chronic Medical Conditions.
- Validation of a novel multibiomarker test to assess rheumatoid Arthritis disease activity.
- Does medication adherence itself confer fracture protection? an investigation of the healthy adherer effect in observational data.
- Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid Arthritis.
- Recent trends in hip fracture rates by race/ethnicity among older US adults.
- Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patient...
- 2012 update of the 2008 american college of rheumatology recommendations for the use of Disease-modifying antirheumatic drugs and biologic agents in the treatment of r...
- Dyslipidemia and changes in lipid profiles associated with rheumatoid Arthritis and initiation of anti-TNF therapy.
- Rates of malignancy associated with juvenile idiopathic Arthritis and its treatment.
- Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic Diseases.
- Predicting future response to certolizumab pegol in rheumatoid Arthritis patients: Features at 12 weeks associated with low disease activity at 1 year.
- Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan.
- Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes.
- Validation of Diagnostic Codes for Subtrochanteric, Diaphyseal, and Atypical Femoral Fractures Using Administrative Claims Data.
- Risk of Herpes Zoster in Auto-immune and Inflammatory Diseases: Implications for Vaccination.
- Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid Arthritis.
- The Risk for Cardiovascular Events Associated with Hyperlipdemia among Patients with and Without Rheumatoid Arthritis.
Schools
Oregon Health And Science University School Of Medicine
Or Health Science University Hospital
Procedures Preformed
- Joint Drainage
- Non-Spinal Nerve Blocks
- Steroid Injection
Conditions Treated
- Adhesive Capsulitis
- Arthritis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- Chronic Neck Pain
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACR)
Education
-
University of Alabama Medical Center -
Oregon Health & Science University -
Oregon Health & Science University School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1669415725 | |
| NPPES Provider LastName | CURTIS | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 2241.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 398.0 | |
| Percent Opioid Claims | 17.76 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669415725 |
| Last Name Of The Provider | CURTIS |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Warren D. Blackburn Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Paul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter W. Chatham, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Guy B. Dewees III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Mountz Sr., MD |
|
|
Dr. Gene L. Watterson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holly M. Bastian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashima Malik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura B. Hughes, MD
This Doctor is OpenDoctor Recommended.
|